It was my pleasure to speak at the #patient day for #USH2025 in Nijmegen today. I was able to share details of the multicentre international phase 2 #Ultevursen clinical trial run by #SepulBio for individuals with exon 13 mutations in the #USH2A gene.

Dr Maria Toms presenting at USH2025. She is standing at a podium on the left, screens projecting her slides in the background, and a sign language interpreter live on a video screen relaying all information to Usher patients in the audience.

Very proud of my post doc Dr Maria Toms who presented today at #USH2025 in Nijmegen, Netherlands on our research on developing a non-viral #GeneTherapy for #USH2A. Thanks to the organisers for a stimulating meeting, and its accessibility 👏🏼 @moorfieldsbrc.bsky.social @ucleye.bsky.social @crick.ac.uk

Please can we connect everyone on #Bluesky with #UsherSyndrome ? That would be so powerful.
I have #USH2A
#DeafBlind
Calling all Usher Syndrome people, organisations!
Please repost to connect us all, maybe we could start a Feed?) @bluesky #boost #JoinIn #OverHeard #Deaf #Blind #DeafSky #BlindSky